News
Cerevance establishes strategic research collaboration with Merck
Cerevance – the clinical-stage drug discovery and development company focused on central nervous system diseases – has announced a multi-year strategic research collaboration with Merck – known as MSD outside the US and Canada – to identify novel targets for Alzheimer’s disease.